Jaguar Health delays Q2 2026 10-Q filing
Jaguar Health, Inc. filed a notice that its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 will be filed late.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jaguar Health, Inc. filed a notice that its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 will be filed late. The company cites delays in obtaining and compiling information, including significant and material subsequent event transactions, and states that these delays could not be resolved without unreasonable effort and expense.
Jaguar Health states that, in reliance on Rule 12b-25, it expects to file the Form 10-Q no later than the fifth calendar day following the prescribed due date. The company also cautions that previously unknown issues related to its financial statements or internal control over financial reporting could be identified and may lead to changes in anticipated results, potential delays beyond the permitted 5-day period, and possible volatility in its stock price.
Insights
Analyzing...
Key Terms
Rule 12b-25 regulatory
subsequent event transactions financial
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Jaguar Health (JAGX) file an NT 10-Q for the June 30, 2026 quarter?
When does Jaguar Health (JAGX) expect to file its delayed June 30, 2026 Form 10-Q?
Does Jaguar Health (JAGX) reference significant subsequent events in connection with the late 10-Q?
Is Jaguar Health (JAGX) indicating a significant change in results of operations in the upcoming 10-Q?
AI-generated analysis. How Rhea-AI works. Not financial advice.